A carregar...
Remyelinating Pharmacotherapies in Multiple Sclerosis
We have witnessed major successes in the development of effective immunomodulatory therapies capable of reducing adaptive immune-mediated myelin damage in MS over the last 30 years. However, until it is possible to prevent MS or initiate treatment before it has already caused lesions there is a need...
Na minha lista:
| Publicado no: | Neurotherapeutics |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer US
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5722779/ https://ncbi.nlm.nih.gov/pubmed/28948533 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13311-017-0577-0 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|